Naidech Andrew M, Beaumont Jennifer L, Berman Michael, Liotta Eric, Maas Matthew B, Prabhakaran Shyam, Kording Konrad, Holl Jane, Cella David
Department of Neurology, Northwestern University, 710 N Lake Shore Drive 11th floor, Chicago, 60611, USA,
Neurocrit Care. 2015 Aug;23(1):22-7. doi: 10.1007/s12028-014-0098-1.
Clinical outcomes are typically assessed by trained staff. We tested the hypothesis that outcomes reported by the patient or a caregiver on the web would be correlated with a validated interview.
We assessed surviving patients with intracerebral and subarachnoid hemorrhage at 1- , 3- , and 12-month follow-up with a validated interview for the modified Rankin Scale (mRS, a validated ordinal scale from 0, no symptoms to 5, severe disability). Health-related quality of life (HRQoL) was assessed on the web with NIH Patient-Reported Outcomes Measurement Information System (PROMIS) and Neuro-QOL using computer adaptive testing by the patient, proxy reporting by a caregiver, or proxy entry by study staff.
A coincident mRS and HRQoL assessment was available for 149 (71 %) of 209 patients at one, three, or 12 months. There were 89 assessments with proxy entry by study staff, 89 by the patient on the web, and 58 with proxy report by a caregiver on the web. PROMIS physical function assessments were completed in median of 4 questions, and T scores were associated with the mRS (P < 0.001), regardless of respondent. Mean T scores in every category of the mRS were different from every other category (P ≤ 0.003 for all). Results were similar for Neuro-QOL mobility.
Web-based HRQoL assessment with NIH PROMIS and Neuro-QOL is feasible and correlated with a validated interview for the mRS. T scores distinguished between individual categories of the mRS, detecting modest differences in physical function and mobility HRQoL that are difficult to detect with the mRS. PROMIS and Neuro-QOL provide powerful and sensitive outcomes for potentially large cohorts.
临床结局通常由经过培训的工作人员进行评估。我们检验了以下假设:患者或照料者在网络上报告的结局与经过验证的访谈结果具有相关性。
我们在1个月、3个月和12个月的随访中,通过对改良Rankin量表(mRS,一种经过验证的有序量表,从0分无症状到5分严重残疾)进行经过验证的访谈,对存活的脑内出血和蛛网膜下腔出血患者进行评估。使用美国国立卫生研究院患者报告结局测量信息系统(PROMIS)和神经生活质量量表(Neuro-QOL)在网络上对健康相关生活质量(HRQoL)进行评估,采用计算机自适应测试,由患者自行完成、照料者代理报告或研究人员代理录入。
在209例患者中的149例(71%)在1个月、3个月或12个月时进行了mRS和HRQoL的同步评估。其中89次评估由研究人员代理录入,89次由患者在网络上完成,58次由照料者在网络上代理报告。PROMIS身体功能评估中位数为4个问题,T评分与mRS相关(P<0.001),与受访者无关。mRS各等级的平均T评分均与其他等级不同(所有P≤0.003)。Neuro-QOL活动能力方面的结果相似。
使用美国国立卫生研究院PROMIS和Neuro-QOL进行基于网络的HRQoL评估是可行的,并且与经过验证的mRS访谈结果相关。T评分能够区分mRS的各个等级,检测出mRS难以检测到的身体功能和活动能力HRQoL方面的微小差异。PROMIS和Neuro-QOL为潜在的大规模队列研究提供了有力且敏感的结局指标。